Skip to content

ConSaJo: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ConSaJo

BE 1000.114.441
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€13,415
2024 · €15,037-€1,622
Equity
€32,396
2024 · €18,981+€13,415
Cash
€31,616
2024 · €23,623+€7,993
Balance sheet total
€42,199
2024 · €28,943+€13,257

Largest movements

2024 to 2025
Assets
  • Cash +€7,993

    up €7,993 (+33.8%), from €23,623 to €31,616

    mainly Net result for the year (+€13,415) and Accrued charges and deferred income (+€516)

  • Receivables within one year +€5,246

    up €5,246 (+110%), from €4,775 to €10,021

    of which Trade receivables: +€4,801

Equity and liabilities
  • Reserves +€13,415

    up €13,415 (+83.9%), from €15,981 to €29,396

  • Trade debts -€728

    down €728 (-83.7%), from €869 to €142

  • Accrued charges and deferred income +€516

    new in 2025: €516

Income statement
  • Gross operating margin -€1,700

    down €1,700 (-8.8%), from €19,357 to €17,657

  • Taxes -€415

    down €415 (-10.1%), from €4,127 to €3,712

  • Financial charges +€335

    up €335 (+446%), from €75 to €410

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €15,037
Gross operating margin -€1,700
Other operating charges -€2
Financial charges -€335
Taxes +€415
Result 2025 €13,415
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€7,993
Investment €0
Financing €0
Cash 2024 €23,623
Net result for the year +€13,415
Receivables within one year -€5,246
Smaller working-capital items -€10
Trade debts -€728
Tax, wage and social debts +€46
Accrued charges and deferred income +€516
Cash 2025 €31,616
brings cash intakes cash out
Every line side by side 29 lines
Line Code 2024 2025 Change %
Total assets 20/58 €28,943 €42,199 +€13,257 +45.8%
Current assets 29/58 €28,943 €42,199 +€13,257 +45.8%
Amounts receivable within one year 40/41 €4,775 €10,021 +€5,246 +110%
Trade receivables 40 €3,933 €8,733 +€4,801 +122%
Other amounts receivable 41 €842 €1,288 +€445 +52.9%
Cash at bank and in hand 54/58 €23,623 €31,616 +€7,993 +33.8%
Deferred charges and accrued income 490/1 €545 €562 +€17 +3.2%
Total equity and liabilities 10/49 €28,943 €42,199 +€13,257 +45.8%
Equity 10/15 €18,981 €32,396 +€13,415 +70.7%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €15,981 €29,396 +€13,415 +83.9%
Distributable reserves 133 €15,981 €29,396 +€13,415 +83.9%
Amounts payable 17/49 €9,961 €9,803 -€158 -1.6%
Amounts payable within one year 42/48 €9,961 €9,287 -€674 -6.8%
Trade debts 44 €869 €142 -€728 -83.7%
Suppliers 440/4 €869 €142 -€728 -83.7%
Taxes, remuneration and social security 45 €4,067 €4,113 +€46 +1.1%
Taxes 450/3 €4,067 €4,113 +€46 +1.1%
Other amounts payable 47/48 €5,025 €5,033 +€8 +0.2%
Accrued charges and deferred income 492/3 - €516 +€516
Other operating charges 640/8 €118 €120 +€2 +1.7%
Gross operating margin 9900 €19,357 €17,657 -€1,700 -8.8%
Operating profit (loss) 9901 €19,239 €17,537 -€1,702 -8.8%
Financial charges 65/66B €75 €410 +€335 +446%
Recurring financial charges 65 €75 €410 +€335 +446%
Profit (loss) for the period before taxes 9903 €19,164 €17,127 -€2,037 -10.6%
Income taxes 67/77 €4,127 €3,712 -€415 -10.1%
Profit (loss) for the period 9904 €15,037 €13,415 -€1,622 -10.8%
Profit (loss) for the period to be appropriated 9905 €15,037 €13,415 -€1,622 -10.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.